US Stock MarketDetailed Quotes
MURA Mural Oncology
- 3.350
- -0.230-6.42%
Close May 29 16:00 ET
- 3.380
- +0.030+0.90%
Post 17:14 ET
56.69MMarket Cap-295P/E (TTM)
3.550High3.310Low177.35KVolume3.510Open3.580Pre Close606.56KTurnover1.16%Turnover RatioLossP/E (Static)16.92MShares57.20052wk High0.24P/B51.14MFloat Cap3.23052wk Low--Dividend TTM15.26MShs Float57.200Historical High--Div YieldTTM6.70%Amplitude3.230Historical Low3.420Avg Price1Lot Size
About Mural Oncology Company
Mural Oncology Plc is a clinical-stage oncology company. It engages in the business of discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.
Company Profile
SymbolMURA
Company NameMural Oncology
Listing DateNov 6, 2023
Founded2017
CEODr. Caroline Loew, PhD
MarketNASDAQ
Employees117
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10 Earlsfort Terrace
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-905-8020
Websitehttp://www.muraloncology.com
Company Executives
- Name
- Position
- Salary
- Dr. Caroline Loew, PhD
- Chief Executive Officer and Director
- 2.52M
- Vicki L. Goodman
- Chief Medical Officer
- 705.58K
- Maiken Keson-Brookes
- Chief Legal Officer
- --
- Adam D. Cutler
- Chief Financial Officer and Principal Accounting Officer
- 743.18K
- Scott T. Jackson, M.B.A.
- Chairman of the Board
- 65.97K
- Dr. Susan Altschuller, M.B.A.,PhD
- Independent Director
- 58.72K
- Dr. Francis M. Cuss, F.R.C.P.,M.B.
- Independent Director
- 58.63K
- Benjamin J. Hickey, M.B.A.
- Independent Director
- 51.79K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg